Trials / Unknown
UnknownNCT04516590
The Diagnostic Value of Autoimmune Antibody Detection in Newly Onset and Chronic Epilepsy
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 130 (estimated)
- Sponsor
- Xijing Hospital · Academic / Other
- Sex
- All
- Age
- 16 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
multi-central and prospectively study the diagnostic value of autoimmune antibody detection in new and chronic epilepsy, and provide reference for clinical practice
Detailed description
multi-centrally recruit patients with newly onset or chronic epilepsy and hoping to find whether there exist an autoimmune cause. whether the patients receive immune therapy or not will depend on the type and titter of the autoimmune antibody as well as the severity of the symptom. At 3 and 6 months later, all patients will be followed-up, and the positive autoimmune antibody will be redetected. the clinical manifest, clinical data, medication and treatment outcome will be recorded and analyzed, to study the diagnostic value of autoimmune antibody detection in new and chronic epilepsy
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | — | There was no intervention in this observational study |
Timeline
- Start date
- 2020-08-01
- Primary completion
- 2021-09-01
- Completion
- 2021-09-01
- First posted
- 2020-08-18
- Last updated
- 2020-08-18
Source: ClinicalTrials.gov record NCT04516590. Inclusion in this directory is not an endorsement.